These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34566353)

  • 1. Will there be a third COVID-19 wave? A SVEIRD model-based study of India's situation.
    Kannan D; Gurusriram R; Banerjee R; Bhattacharjee S; Varadwaj PK
    Indian J Phys Proc Indian Assoc Cultiv Sci (2004); 2021; 95(11):2513-2521. PubMed ID: 34566353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detecting and mitigating simultaneous waves of COVID-19 infections.
    Souyris S; Hao S; Bose S; England ACI; Ivanov A; Mukherjee UK; Seshadri S
    Sci Rep; 2022 Oct; 12(1):16727. PubMed ID: 36202867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plausibility of a third wave of COVID-19 in India: A mathematical modelling based analysis.
    Mandal S; Arinaminpathy N; Bhargava B; Panda S
    Indian J Med Res; 2021 May&Jun; 153(5&6):522-532. PubMed ID: 34643562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination.
    Yang W; Shaman J
    medRxiv; 2021 Nov; ():. PubMed ID: 34845460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 vaccination strategies and policies in India: The need for further re-evaluation is a pressing priority.
    Rackimuthu S; Hasan MM; Bardhan M; Essar MY
    Int J Health Plann Manage; 2022 May; 37(3):1847-1850. PubMed ID: 34510541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An alternative estimation of the death toll of the Covid-19 pandemic in India.
    Guilmoto CZ
    PLoS One; 2022; 17(2):e0263187. PubMed ID: 35171925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The europe second wave of COVID-19 infection and the Italy "strange" situation.
    Bontempi E
    Environ Res; 2021 Feb; 193():110476. PubMed ID: 33221311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccinating a billion people against COVID-19: India's quest for systems leadership in exceptional times.
    Gulati K; Busari J
    Leadersh Health Serv (Bradf Engl); 2021 Nov; ahead-of-print(ahead-of-print):. PubMed ID: 34787981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Media Reporting Relating to COVID-19 Vaccination as a Driver of Vaccine Hesitancy Prior to the Second Wave of the COVID-19 Pandemic in India: A Content Analysis of Newspaper and Digital Media Reports.
    Basu S; Sharma H
    Cureus; 2023 Mar; 15(3):e36750. PubMed ID: 37123709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mega festivals like MahaKumbh, a largest mass congregation, facilitated the transmission of SARS-CoV-2 to humans and endangered animals via contaminated water.
    Patel AK; Mukherjee S; Leifels M; Gautam R; Kaushik H; Sharma S; Kumar O
    Int J Hyg Environ Health; 2021 Aug; 237():113836. PubMed ID: 34481208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 Pandemic in Malegaon: SUTRA over the Three Waves.
    Shivgunde P; Thakare S; Sen S; Kanitkar M; Agrawal M; Vidyasagar M
    Indian J Microbiol; 2023 Sep; 63(3):344-351. PubMed ID: 37781020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hybrid immunity against COVID-19 in different countries with a special emphasis on the Indian scenario during the Omicron period.
    Bhattacharya M; Sharma AR; Dhama K; Agoramoorthy G; Chakraborty C
    Int Immunopharmacol; 2022 Jul; 108():108766. PubMed ID: 35413676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of Serosurveillance and Forecasting the Third Wave of COVID-19 in an Industrial District in India.
    Nag DS; Mishra M; Chaudhry R; Rana F; Rai S; Mehta N; Gupta M
    Cureus; 2021 Sep; 13(9):e18097. PubMed ID: 34557376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Covid-19 Infection in India: A Comparative Analysis of the Second Wave with the First Wave.
    Sarkar A; Chakrabarti AK; Dutta S
    Pathogens; 2021 Sep; 10(9):. PubMed ID: 34578254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. India's pragmatic vaccination strategy against COVID-19: a mathematical modelling-based analysis.
    Mandal S; Arinaminpathy N; Bhargava B; Panda S
    BMJ Open; 2021 Jul; 11(7):e048874. PubMed ID: 34215611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Third Wave of the COVID-19 Pandemic: Prominence of Initial Public Health Interference.
    Mukherjee S; Ray SK
    Infect Disord Drug Targets; 2022; 22(4):e080222200919. PubMed ID: 35135456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamics of COVID-19 in Amazonia: A history of government denialism and the risk of a third wave.
    Ferrante L; Duczmal LH; Capanema E; Steinmetz WAC; Almeida ACL; Leão J; Vassão RC; Fearnside PM; Tupinambás U
    Prev Med Rep; 2022 Apr; 26():101752. PubMed ID: 35242505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. India's efforts to achieve 1.5 billion COVID-19 vaccinations: a narrative review.
    Singh K; Verma A; Lakshminarayan M
    Osong Public Health Res Perspect; 2022 Oct; 13(5):316-327. PubMed ID: 36328236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A supply chain perspective on India's COVID-19 crisis: Lessons from the second wave and preparing for a potential third wave.
    Natarajan KV; Prasad S
    J Glob Health; 2021; 11():03116. PubMed ID: 34737856
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.